Anti-CD86 antibody
Specifications
| Product Cat#: | AB-06-0966 |
| Product type: | Primary antibody |
| Antigen: | CD86 |
| Immunogen: | recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot ( 1:1000-1:2000 ); Immunocytochemistry/Immunofluorescence ( 1:100-1:250 ); Flow Cytometry ( 1:50-1:200 ); Immunoprecipitation |
| Reactivity: | Rat, Human, Mouse |
| Clonality (clone number): | Monoclonal ( SJ20-00 ) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer ( pH7.4 ), 1 % BSA, 40 % glycerol, 0.05 % NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Activation B7-2 antigen 3 Antibody |
| Activation B7-2 Antigen antibody | |
| B-lymphocyte Activation Antigen B7-2 2 Antibody | |
| B-lymphocyte Activation Antigen B7-2 antibody | |
| B7 2 Antibody | |
| B7 Antibody | |
| B7-2 Antibody | |
| B7.2 Antibody | |
| B70 Antibody | |
| B72 Antigen Antibody | |
| BU63 Antibody | |
| CD28 Antigen Ligand 2 2 Antibody | |
| CD28 Antigen Ligand 2 Antibody | |
| Cd28l2 Antibody | |
| CD28LG2 Antibody | |
| CD86 Antibody | |
| CD86 Antigen (CD28 Antigen Ligand 2, B7-2 Antigen) 1, 2 Antibody | |
| CD86 Antigen (CD28 Antigen Ligand 2, B7-2 Antigen) Antibody | |
| CD86 Antigen Antibody | |
| CD86 Molecule Antibody | |
| CLS1 Antibody | |
| CTLA-4 Counter-receptor B7.2 2, 3 Antibody | |
| CTLA-4 Counter-receptor B7.2 Antibody | |
| T-cell Costimulatory Molecule 1 Antibody | |
| ETC-1 Antibody | |
| 1 Antibody | |
| FUN-1 Antibody | |
| LAB72 Antibody | |
| Ly-58 Antibody | |
| MB7 Antibody | |
| -2 Antibody | |
| MGC34413 Antibody | |
| T-lymphocyte Activation Antigen CD86 Antibody | |
| TS/A-2 antibody |
Show More
Target information
Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. May play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation.
(Microbial infection) Acts as a receptor for adenovirus subgroup B.
Provider
Erpantech Laboratory